Neglected Tropical Diseases Diagnosis Market 2026
The Neglected Tropical Diseases Diagnosis Market was valued at in and is anticipated to reach by , at a CAGR of 0.043 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Neglected Tropical Diseases Diagnosis Market.
This report delivers a comprehensive overview of the Neglected Tropical Diseases Diagnosis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis Market. The Neglected Tropical Diseases Diagnosis Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Neglected Tropical Diseases Diagnosis Market Scope:
By Disease
This report delivers a comprehensive overview of the Neglected Tropical Diseases Diagnosis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis Market. The Neglected Tropical Diseases Diagnosis Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Neglected Tropical Diseases Diagnosis Market.
This report delivers a comprehensive overview of the Neglected Tropical Diseases Diagnosis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis Market. The Neglected Tropical Diseases Diagnosis Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Neglected Tropical Diseases Diagnosis Market Scope:
By Disease
- Dengue
- Chikungunya
- Rabies
- Lymphatic Filariasis
- Buruli Ulcer
- Leprosy
- Others
- Conventional Method
- Molecular Method
- Centralized Service
- Point-of-care Testing
- Hospitals
- Clinical Laboratories
- Others
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Coris BioConcept
- Genome Diagnostics Pvt. Ltd
- InBios International, Inc.
- Oscar Medicare Pvt Ltd.
- Thermo Fisher Scientific, Inc.
- ZeptoMetrix, LLC
- Premier Medical Corporation Ltd.
- EUROIMMUN Medizinische Labordiagnostika AG(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Neglected Tropical Diseases Diagnosis Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis Market. The Neglected Tropical Diseases Diagnosis Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Disease
3.2. Market Snippet by Diagnostic Method
3.3. Market Snippet by Service Type
3.4. Market Snippet by End User
3.5. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovative technologies to diagnose Neglected Tropical Diseases are expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. The high costs of diagnostic tests and kits are expected to hamper in the forecast period.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Supply Chain Analysis
5.2. Pricing Analysis
5.3. Unmet Needs
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY DISEASE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
7.1.2. Market Attractiveness Index, By Disease Segment
7.2. Dengue*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Chikungunya
7.4. Rabies
7.5. Lymphatic Filariasis
7.6. Buruli Ulcer
7.7. Leprosy
7.8. Others
8. BY DIAGNOSTIC METHOD
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
8.1.2. Market Attractiveness Index, By Diagnostic Method Segment
8.2. Conventional Method*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Molecular Method
9. BY SERVICE TYPE
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
9.1.2. Market Attractiveness Index, By Service Type Segment
9.2. Centralized Service*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Point-of-care Testing
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.1.2. Market Attractiveness Index, By End user Segment
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Clinical Laboratories
10.4. Others
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch
13. COMPANY PROFILES
13.1. Abbott Laboratories*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Bio-Rad Laboratories, Inc.
13.3. Coris BioConcept
13.4. Genome Diagnostics Pvt. Ltd
13.5. InBios International, Inc.
13.6. Oscar Medicare Pvt Ltd.
13.7. Thermo Fisher Scientific, Inc.
13.8. ZeptoMetrix, LLC
13.9. Premier Medical Corporation Ltd.
13.10. EUROIMMUN Medizinische Labordiagnostika AG(*LIST NOT EXHAUSTIVE)
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Disease
3.2. Market Snippet by Diagnostic Method
3.3. Market Snippet by Service Type
3.4. Market Snippet by End User
3.5. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovative technologies to diagnose Neglected Tropical Diseases are expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. The high costs of diagnostic tests and kits are expected to hamper in the forecast period.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Supply Chain Analysis
5.2. Pricing Analysis
5.3. Unmet Needs
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY DISEASE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
7.1.2. Market Attractiveness Index, By Disease Segment
7.2. Dengue*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Chikungunya
7.4. Rabies
7.5. Lymphatic Filariasis
7.6. Buruli Ulcer
7.7. Leprosy
7.8. Others
8. BY DIAGNOSTIC METHOD
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
8.1.2. Market Attractiveness Index, By Diagnostic Method Segment
8.2. Conventional Method*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Molecular Method
9. BY SERVICE TYPE
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
9.1.2. Market Attractiveness Index, By Service Type Segment
9.2. Centralized Service*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Point-of-care Testing
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.1.2. Market Attractiveness Index, By End user Segment
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Clinical Laboratories
10.4. Others
11. BY REGION
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Method
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Type
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch
13. COMPANY PROFILES
13.1. Abbott Laboratories*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Bio-Rad Laboratories, Inc.
13.3. Coris BioConcept
13.4. Genome Diagnostics Pvt. Ltd
13.5. InBios International, Inc.
13.6. Oscar Medicare Pvt Ltd.
13.7. Thermo Fisher Scientific, Inc.
13.8. ZeptoMetrix, LLC
13.9. Premier Medical Corporation Ltd.
13.10. EUROIMMUN Medizinische Labordiagnostika AG(*LIST NOT EXHAUSTIVE)
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us
